References
- Alves de Souza, C. E., H. M. Alves de Souza, M. C. Stipp, C. R. Corso, C. M. Galindo, C. R. Cardoso, R. L. Dittrich, E. A. de Souza Ramos, G. Klassen, R. M. Carlos, et al. 2017. Ruthenium complex exerts antineoplastic effects that are mediated by oxidative stress without inducing toxicity in Walker-256 tumor-bearing rats. Free Radic. Biol. Med. 110:228–39. doi:https://doi.org/10.1016/j.freeradbiomed.
- Amara, S., T. Douki, C. Garel, A. Favier, M. Sakly, K. Rhouma, H. Abdelmelek. 2009. Effects of static magnetic field exposure on antioxidative enzymes activity and DNA in rat brain. Gen. Physiol. Biophys. 28:260–65. doi:https://doi.org/10.4149/gpb_2009_03_260.
- Barnes, F., and B. Greenebaum. 2018. Role of radical pairs and feedback in weak radio frequency field effects on biological systems. Environ. Res. 163:165–70. doi:https://doi.org/10.1016/j.envres.2018.01.038.
- Bauer, G. 2014. Targeting extracellular ROS signaling of tumor cells. Anticancer Res. 34:1467–82.
- Bernini, M., and L. Bencini. 2012. Multimodal treatment of gastric cancer: Surgery, chemotherapy, radiotherapy, and timing. Int. J. Surg. Oncol. (2012:246290. doi:https://doi.org/10.1155/2012/246290.
- Birben, E., U. M. Sahiner, C. Sackesen, S. Erzurum, O. Kalayci. 2012. Oxidative stress and antioxidant defence. World Allergy Organ. J. 5:9–19. doi:https://doi.org/10.1097/WOX.0b013e3182439613.
- Boroday, N. V., and V. F. Chekhun. 2018. Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells. Exp. Oncol. 40:42–47. doi:https://doi.org/10.31768/2312-8852.2018.40(1):42-47.
- Bystrom, L. M., and S. Rivella. 2015. Cancer cells with irons in the fire. Free Radic. Biol. Med. 79:337–42. doi:https://doi.org/10.1016/j.freeradbiomed.2014.04.035.
- Cameron, I. L., M. S. Markov, and W. E. Hardman. 2014. Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity. Cancer Cell Int. 14:125. doi:https://doi.org/10.1186/s12935-014-0125-5.
- Carpenter, D. O. 2010. Electromagnetic fields and cancer: The cost of doing nothing. Rev. Environ. Health. 25:75–80. doi:https://doi.org/10.1515/reveh.2010.25.1.75.
- Casciato, D. A. 2009. Manual of clinical oncology. Philadelphia: Lippincott Williams & Wilkins, Wolters, Kluwer.
- Cichoz-Lach, H., and A. Michalak. 2014. Oxidative stress as a crucial factor in liver diseases. World J. Gastroenterol. 20:8082–91. doi:https://doi.org/10.3748/wjg.v20.i25.8082.
- Copur, M. S. 2019. State of cancer research around the globe. Oncology (Williston Park) 33:181–85.
- Davies, M. J. 2016. Protein oxidation and peroxidation. Biochem. J. 473:805–25. doi:https://doi.org/10.1042/BJ20151227.
- Deminice, R., S. Padilha Cde, F. Borges, L. E. C. M. Da Silva, F. T. Rosa, J. L. Robinson, R. Cecchini, F. A. Guarnier, F. T. Frajacomo. 2016. Resistance exercise prevents impaired homocysteine metabolism and hepatic redox capacity in Walker-256 tumor-bearing male Wistar rats. Nutrition 32:1153–58. doi:https://doi.org/10.1016/j.nut.2016.03.008.
- Devrim, E., I. Ergüder, B. Kiliçoglu, E. Yaykaşlı, R. Çetin, İ. Durak. 2008. Effects of electromagnetic radiation use on oxidant/antioxidant status and DNA turn-over enzyme activities in erythrocytes and heart, kidney, liver, and ovary tissues from rats: Possible protective role of vitamin C. Toxicol. Mech. Methods 18:679–83. doi:https://doi.org/10.1080/15376510701380182.
- Dirican, N., A. Dirican, O. Sen, A. Aynali, S. Atalay, H. A. Bircan, O. Oztürk, S. Erdogan, M. Cakir, A. Akkaya, et al. 2016. Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer? Redox Report 21:197–203. doi:https://doi.org/10.1179/1351000215Y.0000000027.
- Emanuel, N. 1982. Kinetics of experimental tumor processes. Oxford: Pergamon Press.
- Faraji, B., H. K. Kang, and J. L. Valentine. 1987. Methods compared for determining glutathione peroxidase activity in blood. Clin. Chem. 33:539–43. doi:https://doi.org/10.1093/clinchem/33.4.539.
- Ferlay, J., M. Colombet, I. Soerjomataram, C. Mathers, D. M. Parkin, M. Piñeros, A. Znaor, F. Bray. 2019. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144:1941–53. doi:https://doi.org/10.1002/ijc.31937.
- Formelli, F., R. Carsana, and C. Pollini. 1986. Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4ʹ-O-methyldoxorubicin in tumor-bearing mice. Cancer Chemother. Pharmacol. 16:15–21. doi:https://doi.org/10.1007/BF00255280.
- Gastwirt, J. P., and M. Roschewski. 2018. Management of adults with Burkitt lymphoma. Clin. Adv. Hematol. Oncol. 16:812–22.
- Gewirtz, D. A., M. L. Bristol, and J. C. Yalowich. 2010. Toxicity issues in cancer drug development. Curr. Opin. Investig. Drugs. 11:612–14.
- Ghodbane, S., M. Ammari, A. Lahbib, M. Sakly, H. Abdelmelek. 2015. Static magnetic field exposure-induced oxidative response and caspase-independent apoptosis in rat liver: Effect of selenium and vitamin E supplementations. Environ. Sci. Pollut. Res. Int 22:16060–66. doi:https://doi.org/10.1007/s11356-015-4802-2.
- Glazer, E. J., and S. A. Curley. 2011. The ongoing history of thermal therapy for cancer. Surg. Oncol. Clin. N. Am. 20:229–35. doi:https://doi.org/10.1016/j.soc.2010.11.001.
- Goth, L. 1991. A simple method for determination of serum catalase activity and revision of reference range. Clinica Chimica Acta 196:143–51. doi:https://doi.org/10.1016/0009-8981(91)90067-m.
- Guillen, J. 2012. FELASA Guidelines and Recommendations. J. Am. Assoc. Lab. Anim. Sci. 51:311–21.
- Haanen, J. B. A. G., F. Carbonnel, C. Robert, K. M. Kerr, S. Peters, J. Larkin, K. Jordan. 2017. Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. ESMO guidelines committee. Ann. Oncol. 28:119–42. doi:https://doi.org/10.1093/annonc/mdx225.
- Hargrove, L., L. Kennedy, J. Demieville, H. Jones, F. Meng, S. DeMorrow, W. Karstens, T. Madeka, J. Greene, H. Francis, et al. 2017. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit W-sh mice. Hepatology 65:1991–2004. doi:https://doi.org/10.1002/hep.29079.
- Harris, I. S., and G. M. DeNicola. 2020. The complex interplay between antioxidants and ROS in cancer. Trends Cell Biol. 30:440–51. doi:https://doi.org/10.1016/j.tcb.2020.03.002.
- Harris, I. S., A. E. Treloar, S. Inoue, M. Sasaki, C. Gorrini, K. Lee, K. Yung, D. Brenner, C. Knobbe-Thomsen, M. Cox, et al. 2015. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27:211–22. doi:https://doi.org/10.1016/j.ccell.2014.11.019.
- Hawk, M. A., C. McCallister, and Z. T. Schafer. 2016. Antioxidant activity during tumor progression: A necessity for the survival of cancer cells? Cancers 8:92. doi:https://doi.org/10.3390/cancers8100092.
- Houston, B. J., B. Nixon, B. V. King, G. N. De Iuliis, R. J. Aitken. 2016. The effects of radiofrequency electromagnetic radiation on sperm function. Reproduction 152:R263–R276. doi:https://doi.org/10.1530/REP-16-0126.
- Jin, Z., C. Zong, B. Jiang, Z. Zhou, J. Tong, Y. Cao. 2012. The effect of combined exposure of 900 MHz radiofrequency fields and doxorubicin in HL-60 cells. PLoS ONE 7:e46102. doi:https://doi.org/10.1371/journal.pone.0046102.
- Joshi, G., R. Sultana, J. Tangpong, M. P. Cole, D. K. St Clair, M. Vore, S. Estus, D. A. Butterfield. 2005. Free radical mediated oxidative stress and toxic side effects in brain induced by the anti-cancer drug adriamycin: Insight into chemobrain. Free Radic. Res. 39:1147–54. doi:https://doi.org/10.1080/10715760500143478.
- Jumes, F. M., D. Lugarini, A. L. Pereira, A. de Oliveira, A. D. O. Christoff, G. A. Linde, J. S. do Valle, N. B. Colauto, A. Acco. 2010. Effects of Agaricus brasiliensis mushroom in Walker-256 tumor-bearing rats. Can. J. Physiol. Pharmacol 88:21–27. doi:https://doi.org/10.1139/Y09-111.
- Kiernan, J. 2008. Histological and histochemical methods: Theory and practice. 4th ed. New York: Cold Spring Harbor Laboratory Press.
- Klimanov, M. Y., L. A. Syvak, V. E. Orel, G. V. Lavryk, T. Y. Tarasenko, V. B. Orel, A. Y. Rykhalskyi, V. V Stegnii, A. O. Nesterenko. 2018 Efficacy of combined regional inductive moderate hyperthermia and chemotherapy in patients with multiple liver metastases from breast cancer. Technol. Cancer Res. Treat. 17. doi:https://doi.org/10.1177/1533033818806003.
- Kocaman, A., G. Altun, A. A. Kaplan, Ö. G. Deniz, K. K. Yurt, S. Kaplan. 2018. Genotoxic and carcinogenic effects of non-ionizing electromagnetic fields. Environ. Res 163:71–79. doi:https://doi.org/10.1016/j.envres.2018.01.034.
- Kuzu, M., S. Yildirim, F. M. Kandemir, S. Küçükler, C. Çağlayan, E. Türk, M. B. Dörtbudak. 2019. Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats. Chem. Biol. Interact. 308:89–100. doi:https://doi.org/10.1016/j.cbi.2019.05.017.
- Lai, H. 2019. Exposure to static and extremely-low frequency electromagnetic fields and cellular free radicals. Electromagn. Biol. Med. 38:231–48. doi:https://doi.org/10.1080/15368378.2019.1656645.
- Li, S., H. Y. Tan, N. Wang, Z.-J. Zhang, L. Lao, C.-W. Wong, Y. Feng. 2015. The role of oxidative stress and antioxidants in liver diseases. Int. J. Mol. Sci. 16:26087–124. doi:https://doi.org/10.3390/ijms161125942.
- Luo, M., L. Shang, M. D. Brooks, E. Jiagge, Y. Zhu, J. M. Buschhaus, S. Conley, M. A. Fath, A. Davis, E. Gheordunescu, et al. 2018. Targeting breast cancer stem cell state equilibrium through modulation of redox signaling. Cell Metab. 28:69–86. doi:https://doi.org/10.1016/j.cmet.2018.06.006.
- Lushnikova, E. L., E. V. Ovsyanko, L. M. Nepomnyashchikh, A. V. Efremov, D. V. Morozov. 2011. Proliferation of Walker 256 carcinosarcoma cells: Effect of whole-body hyperthermia and antitumor agents. Bull. Exp. Biol. Med. 152:146–52. doi:https://doi.org/10.1007/s10517-011-1475-9.
- Martínez-Sámano, J., P. V. Torres-Durán, M. A. Juárez-Oropeza, D. Elías-Viñas, L. Verdugo-Díaz. 2010. Effects of acute electromagnetic field exposure and movement restraint on antioxidant system in liver, heart, kidney and plasma of Wistar rats: A preliminary report. Int. J. Radiat. Biol. 86:1088–94. doi:https://doi.org/10.3109/09553002.2010.501841.
- Mattsson, M. O., and M. Simko. 2019. Emerging medical applications based on non-ionizing electromagnetic fields from 0 Hz to 10 THz. Med. Devices (Auckl). 12:347–68. doi:https://doi.org/10.2147/MDER.S214152.
- Muramatsu, Y., T. Matsui, M. Deie, K. Sato. 2017. Pulsed electromagnetic field stimulation promotes anti-cell proliferative activity in doxorubicin-treated Mouse Osteosarcoma Cells. Vivo 31:61–68. doi:https://doi.org/10.21873/invivo.11026.
- Nakata, Y., and A. J. Hopfinger. 1980. An extended conformational analysis of doxorubicin. FEBS Letter 117:259–64. doi:https://doi.org/10.1016/0014-5793(80)80957-4.
- Naruphontjirakul, P., and K. Viravaidya-Pasuwat. 2019. Development of anti-HER2-targeted doxorubicin-core-shell chitosan nano-particles for the treatment of human breast cancer. Int. J. Nanomedicine. 14:4105–21. doi:https://doi.org/10.2147/IJN.S198552.
- Odaci, E., D. Ünal, T. Mercantepe, Z. Topal, H. Hancı, S. Türedi, H. Erol, S. Mungan, H. Kaya, S. Çolakoğlu, et al. 2015. Pathological effects of prenatal exposure to a 900 MHz electromagnetic field on the 21-day-old male rat kidney. Biotech. Histochem 90:93–101. doi:https://doi.org/10.3109/10520295.2014.947322.
- Omote, Y., M. Hosokawa, M. Komatsumoto, T. Namieno, S. Nakajima, Y. Kubo, H. Kobayashi. 1990. Treatment of experimental tumors with a combination of a pulsing magnetic field and an antitumor drug. Jpn. J. Cancer Res 81:956–61. doi:https://doi.org/10.1111/j.1349-7006.1990.tb02673.x.
- Orel, V., T. Kozarenko, K. Galachin, A. Romanov, A. Morozoff. 2007. Nonlinear analysis of digital images and doppler measurements for trophoblastic tumor. Nonlinear Dyn. Psychol. Life Sci 11:309–31.
- Orel, V., A. Shevchenko, A. Romanov, M. Tselepi, T. Mitrelias, C. H. W. Barnes, A. Burlaka, S. Lukin, I. Shchepotin. 2014. Magnetic properties and antitumor effect of nanocomplexes of iron oxide and doxorubicin. Nanomedicine 11:47–55. doi:https://doi.org/10.1016/j.nano.2014.07.007.
- Orel, V. B., M. A. Zabolotny, and V. E. Orel. 2017. Heterogeneity of hypoxia in solid tumours and mechanochemical reactions with oxygen nanobubbles. Med. Hypotheses. 102:82–86. doi:https://doi.org/10.1016/j.mehy.2017.03.006.
- Orel, V. E., S. I. Korovin, J. Molnár, V. B. Orel. 2019b. Non-linear dynamics theory and malignant melanoma. Exp. Oncol. 41:291–99. doi:https://doi.org/10.32471/exp-oncology.2312-8852.vol-41-no-4.13672.
- Orel, V. E., M. Tselepi, T. Mitrelias, A. Rykhalskyi, A. Romanov, V. B. Orel, A. Shevchenko, A. Burlaka, S. Lukin, C. H. W. Barnes. 2018. Nanomagnetic modulation of tumor redox state. Nanomedicine: Nanotechnology, Biology and Medicine 14:1249–56. doi:https://doi.org/10.1016/j.nano.2018.03.002.
- Orel, V. E., M. Tselepi, T. Mitrelias, M. Zabolotny, M. Krotevich, A. Shevchenko, A. Rykhalskyi, A. Romanov, V. B. Orel, A. Burlaka, et al. 2019a. Nonlinear magnetochemical effects in nanotherapy of Walker-256 carcinosarcoma. ACS Appl. Bio. Mater 2:3954–63. doi:https://doi.org/10.1021/acsabm.9b00526.
- Ozgur, E., G. Güler, and N. Seyhan. 2010. Mobile phone radiation-induced free radical damage in the liver is inhibited by the anti-oxidants N-acetyl cysteine and epigallocatechin-gallate. Int. J. Radiat. Biol. 86:935–45. doi:https://doi.org/10.3109/09553002.2010.496029.
- Pliss, E. M., A. M. Grobov, A. K. Kuzaev, A. L. Buchachenko. 2017. Magnetic field effect on the oxidation of hydrocarbons by mo-lecular oxygen. Mendeleev Commun 27:246–47. doi:https://doi.org/10.1016/j.mencom.2017.05.009.
- Safdie, F., S. Brandhorst, M. Wei, W. Wang, C. Lee, S. Hwang, P. S. Conti, T. C. Chen, V. D. Longo. 2012. Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One 7:e44603. doi:https://doi.org/10.1371/journal.pone.0044603.
- Salbitani, G., V. Vona, C. Bottone, M. Petriccione, S. Carfagna. 2015. Sulfur deprivation results in oxidative perturbation in Chlorella sorokiniana (211/8k). Plant Cell Physiol. 56:897–905. doi:https://doi.org/10.1093/pcp/pcv015.
- Sanchez-Valle, V., N. C. Chavez-Tapia, M. Uribe, N. Mendez-Sanchez. 2012. Role of oxidative stress and molecular changes in liver fibrosis. Curr. Med. Chem. 19:4850–60. doi:https://doi.org/10.2174/092986712803341520.
- Schatten, W. E. 1962. An experimental study of necrosis in tumors. Cancer Res. 22:286–90.
- Shaw, R., S. Miller, J. Curwen, M. Dymond. 2017. Design, analysis and reporting of tumor models. Lab Anim 46:207–11. doi:https://doi.org/10.1038/laban.1257.
- Simkó, M. 2007. Cell type specific redox status is responsible for diverse electromagnetic field effects. Curr. Med. Chem. 14:1141–52. doi:https://doi.org/10.2174/092986707780362835.
- Tatarov, I., A. Panda, D. Petkov, K. Kolappaswamy, K. Thompson, A Kavirayani, M. M. Lipsky, E. Elson, C. C. Davis, S. S. Martin, et al. 2011. Effect of magnetic fields on tumor growth and viability. Comp. Med. 61:339–45.
- Tayek, J. A., N. W. Istfan, C. T. Jones, K. J. Hamawy, B. R., Bistrian, G. L. Blackburn. 1986. Influence of the Walker 256 carcinosarcoma of muscle, tumor, and whole-body protein synthesis and growth rate in the cancer-bearing rat. Cancer Res. 46:5649–54.
- Thoolen, B., R. R. Maronpot, T. Harada, A. Nyska, C. Rousseaux, T. Nolte, D. E. Malarkey, W. Kaufmann, K. Küttler, U. Deschl, et al. 2010. Proliferative and nonpro-liferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol 38:5S–81S. doi:https://doi.org/10.1177/0192623310386499.
- Thorn, C. F., C. Oshiro, S. Marsh, T. Hernandez-Boussard, H. McLeod, T. E. Klein, R. B. Altman. 2011. Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenet. Genomics 21:440–46. doi:https://doi.org/10.1097/FPC.0b013e32833ffb56.
- Tipple, T. E., and L. K. Rogers. 2012. Methods for the determination of plasma or tissue glutathione levels. Methods Mol Biol 889:315–24. doi:https://doi.org/10.1007/978-1-61779-867-2_20.
- Topuz, M., O. Şen, M. Kaplan, O. Akkus, O. Erel, M. Gur. 2017. The role of thiol/disulphide homeostasis in anthracycline as-sociated cardiac toxicity. Int. Heart J 58:69–72. doi:https://doi.org/10.1536/ihj.16-124.
- Tukozkan, N., H. Erdamar, and I. Seven. 2006. Measurement of total malondialdehyde in plasma and tissues by high-performance liquid chromatography and thiobarbituric acid assay. Firat. Tip. Dergis. 11:88–92.
- Upshaw, J. N., R. Ruthazer, K. D. Miller, S. K. Parsons, J. K. Erban, A. M. O’Neill, B. Demissei, G. Sledge, L. Wagner, B. Ky, et al. 2019. Personalized decision making in early stage breast cancer: Applying clinical prediction models for anthracycline cardiotoxicity and breast cancer mortality demonstrates substantial heterogeneity of benefit-harm trade-off. Clin. Breast. Cancer 19:259–67. doi:https://doi.org/10.1016/j.clbc.2019.04.012.
- Usselman, R. J., I. Hill, D. J. Singel, C. F. Martino, et al. 2014. Spin biochemistry modulates reactive oxygen species (ROS) production by radio frequency magnetic fields. PLoS ONE 9.e93065. doi:https://doi.org/10.1371/journal.pone.0093065.
- Videla, L. A. 2009. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J. Hepatol. 1:72–78. doi:https://doi.org/10.4254/wjh.v1.i1.72.
- Walton, E. L. 2016. The dual role of ROS, antioxidants and autophagy in cancer. Biomed. J. 39:89–92. doi:https://doi.org/10.1016/j.bj.2016.05.001.
- Wieczorek, A., P. M. Stępień, D. Zarębska-Michaluk, W. Kryczka, P. Pabjan, T. Król. 2017. Megamitochondria formation in hepatocytes of patient with chronic hepatitis C - a case report. Clin. Exp. Hepatol 3:169–75. doi:https://doi.org/10.5114/ceh.2017.68287.
- Wust, P., B. Kortüm, U. Strauss, J. Nadobny, S. Zschaeck, M. Beck, U. Stein, P. Ghadjar. 2010. Non-thermal effects of radiofrequency electromagnetic fields. Sci Rep 10:13488. doi:https://doi.org/10.1038/s41598-020-69561-3.
- Xu, A., Q. Wang, X. Lv, T. Lin. 2021. Progressive study on the non-thermal effects of magnetic field therapy in oncology. Front. Oncol. 11:638146. doi:https://doi.org/10.3389/fonc.2021.638146.
- Yamashita, N., Y. Kanno, N. Saito, K. Terai, N. Sanada, R. Kizu, N. Hiruta, Y. Park, H. Bujo, K. Nemoto 2019. Aryl hydro-carbon receptor counteracts pharmacological efficacy of doxorubicin via enhanced AKR1C3 expression in triple negative breast cancer cells. Biochem. Biophys. Res. Commun. 516:693–98. doi:https://doi.org/10.1016/j.bbrc.2019.06.119.
- Zorov, D. B., M. Juhaszova, and S. J. Sollott. 2014. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94:909–50. doi:https://doi.org/10.1152/physrev.00026.2013.